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Risk factors for asymptomatic abdominal 
aortic aneurysm
Systematic review and meta-analysis of population-based screening studies
JACQUES CORNUZ, CLAUDIO SIDOTI PINTO, HEINDRIK TEVAEARAI, MATTHIAS EGGER *
Background: The incidence of and mortality from ruptured abdominal aortic aneurysm (AAA) is increasing. There is uncertainty
regarding the indicators which could be used to identify groups at high risk. This issue has been addressed in a systematic
review of population-based screening studies. Methods: MEDLINE and EMBASE were searched, reference lists scanned and
manual searches made of eight journals. The search was restricted to four languages (English, German, French and Italian).
Population-based studies investigating risk factors associated with screening-detected AAA were included. The following risk
factors were considered: sex, smoking, hypertension, diabetes, a history myocardial infarction, and peripheral vascular disease.
Results: Fourteen cross-sectional studies met our inclusion criteria. Most studies screened people aged 60 years or older. The
prevalence of AAA ranged from 4.1% to 14.2% in men and from 0.35% to 6.2% in women. Male sex showed a strong association
with AAA (OR 5.69), whereas smoking (OR 2.41), a history of myocardial infarction (OR 2.28) or peripheral vascular disease
(OR 2.50) showed moderate associations. Hypertension was only weakly associated with AAA (OR 1.33) and no association
was evident with diabetes (OR 1.02). Conclusions: The efficacy of screening men aged 60 years or older and women of the
same age who smoke or have a history of peripheral or coronary artery disease should be evaluated in randomized controlled
trials.
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Abdominal aortic aneurysm (AAA) is defined as a permanent
dilatation of the abdominal aorta. AAA usually remains
asymptomatic unless it ruptures; a catastrophic event which is
associated with high mortality rate, even in situations when time
permits emergency surgery.1 The aetiology of AAA is not fully
understood but atherosclerosis, degenerative changes of the
media with alterations in elastin and collagen, and chronic
inflammation have been identified as contributing to its patho-
genesis.2,3
AAA appears to meet many of the classic criteria4 of screening
for disease. First, AAA is an important health problem. In
cross-sectional studies the prevalence varies according to the
definition of AAA and the setting, with prevalences ranging
from 3% to 8%.5 The incidence of asymptomatic AAA has
increased in several countries during the last decades. For
example, a national study from Denmark reported an increase in
the incidence of asymptomatic lesions from 7.1 per 100,000 to
25.8 per 100,000 person-years.6 This trend could be explained by
case-finding resulting from increased use of ultrasonography.
However, the incidence of ruptured AAA and of age-
standardized mortality also increased, indicating a real increase
in the incidence of AAA. In the USA, the number of deaths
attributed to AAA increased by almost 20% between 1979 and
1991. In 1991, 16,696 deaths were attributed to aortic aneurysm,
abdominal aneurysm accounting for 52%.7 Secondly, abdominal
ultrasound is a suitable test, which is non-invasive, relatively
inexpensive and nearly 100% accurate in identifying the
presence or absence of clinically relevant AAA.8 Thirdly,
elective surgery is an effective treatment for patients with
recognized disease. The mortality rate of elective surgery is
around 5%, but about ten times higher in emergency inter-
ventions.1,9 Since many patients die before reaching the hospital
or before surgery can be arranged the mortality rate from ruptured
AAA overall is 80% to 90%.1 Finally, economic modelling
suggests that screening may be cost-effective.10
The question whether screening for AAA should be introduced
and who should be screened has been debated for some time.11,12
Authorities in the USA and Canada argued that there was
insufficient evidence to recommend for or against routine
screening of asymptomatic adults for AAA,13,14 whereas other
authors recommended screening of high risk groups, such as
current smokers.10,11 It is unclear, however, what risk factors
could potentially be used to identify groups at high risk in
whom screening might be cost-effective. We addressed this issue
in a systematic review and meta-analysis of population-based
screening studies.
METHODS
Literature search
We searched the MEDLINE and EMBASE databases using the
following keywords and expressions in Ovid to identify relevant
articles dealing with aortic aneurysm: ‘aortic aneurysm,
abdominal/’; ‘aortic rupture/’; ‘aorta, abdominal/’; ‘exp
aneurysm,ruptured/’; ‘(aortic adj5 aneurysm$).tw.’; ‘(abdominal
adj5 dilatation).tw.’; ‘(abdominal adj5 aneurysm$).tw.’;
‘(thoracoabdominal adj5 aneurysm$).tw.’ These eight searches
were combined with the Boolean ‘OR’ operator. Separate
searches were performed to identify suitable study designs, using
expressions ‘exp cohort studies/’; ‘exp risk/’; ‘(odds and
ratio$).tw.’; ‘(relative and risk).tw.’; ‘(case and control$).tw.’.
The results from the search on aortic aneurysm was then
combined with the search of relevant study designs. We com-
plemented this search by scanning the reference lists of relevant
articles and manual searches of New England Journal of Medicine,
The Lancet, Annals of Internal Medicine, Circulation, JAMA,
American Journal of Public Health, BMJ, Journal of Medical
Screening, and British Journal of Surgery. We restricted our search
to four languages (English, German, French and Italian) and to
the period 1985 to 1998. We excluded earlier studies because
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ultrasound technology was not available before 1985. The search
is described in detail elsewhere.15
Inclusion criteria
We included all original reports from population-based studies
investigating factors associated with screening-detected AAA.
Study populations identified from censuses, lists of health care
providers, or from other membership lists were eligible. We
excluded studies based on patients attending hospital or out-
patient clinics and studies not providing a clear definition of
AAA. Two of us (JC, CSP) independently performed a first
selection of the retrieved articles on the basis of title and abstract.
Inter-observer agreement was good (kappa=0.60).16 Disagree-
ment was resolved by consensus.
Data extraction
The following data were independently abstracted by two of us
(JC, CSP): study design, setting, AAA screening method and
definition of AAA, the number of people invited to be screened,
the number screened, and the number with AAA. The number
of study participants with and without risk factors in AAA and
comparison groups, and definitions for risk factors were also
extracted in duplicate. The following risk factors were
considered: sex, smoking, hypertension, diabetes, a history
myocardial infarction, and peripheral vascular disease. In-
consistencies in abstracted data were resolved by consensus.
Data synthesis and exploration of heterogeneity
We calculated the prevalence of AAA as the number of study
participants with AAA divided by the number with successful
ultrasound examinations. We determined prevalence separately
for men and women whenever possible and calculated exact
binomial 95% confidence intervals (CIs). Risk factor associ-
ations were expressed as odds ratios (ORs) to obtain consistency
across studies. Only a few authors have performed multivariable
analyses, and those who did included different sets of variables
in their models. We therefore used crude odds ratios throughout.
We combined studies both by DerSimonian and Laird random-
effects and Mantel–Haenszel fixed-effects models.17 We
calculated standard tests of homogeneity and explored sources of
heterogeneity between studies using meta-regression models.
Covariates considered included the year of publication, country
(United Kingdom or other), whether the study included men
only, and the prevalence of AAA found. The regression model
of treatment effect on covariates used an overdispersion
parameter (in the terminology of Thompson and Sharp18) to
allow for residual heterogeneity between studies. We explored
potential publication bias by examining the symmetry of funnel
plots, using a regression approach.19 All analyses were done using
the statistical package Stata version 6 (Stata Corporation,
College Station, Texas, USA).
RESULTS
A total of 2238 articles were identified of which 185 (8.3%) were
considered to be potentially relevant and assessed in detail.
Eighteen articles (0.80%) from 14 studies met our inclusion
criteria. Figure 1 gives a schematic representation of the selection
process and reasons for excluding studies. The characteristics of
the 14 included studies are summarised in table 1. All studies were
based on general population samples and used abdominal ultra-
sound as screening test. Nine enrolled people registered with
general practices, health maintenance organisations, Medicaire
or Veterans Affairs medical centres, three were census based and
one study enrolled customers of bowling clubs, shopping centres
and residents of a retirement village. All studies were cross-
sectional except for one20 which included a cross-sectional study
as well as was a case-control study. Four analyses were based on
populations enrolled in cohort studies: The Men born in 1914
from Malmö cohort,21 the Rotterdam Study,22 the US Cardio-
vascular Health Study23 and the Edinburgh Artery Study.20 The
proportion of those invited who attended screening ranged from
28.5% in the large US veterans study24 to 84.2% in the Cardio-
vascular Health Study. The number of people screened ranged
from 375 in the Swedish study21 to 73,451 in the US veterans
study.24
The definitions used for AAA varied between studies although
seven of the 14 studies used a similar definition (a diameter
greater than 28–30 mm) (table 2). The denominator in the
calculation of prevalence was sometimes smaller than the total
number screened because the aorta could not always be
visualized. The study from Norway25 reported on the first 500
study participants only. The prevalence of AAA ranged from
4.1% to 14.2% in men and from 0.35% to 6.2% in women.
The definitions used by authors for the different risk factors or
risk indicators were also heterogeneous across studies (table 3).
For example, some investigators relied on a history of claudica-
tion for the definition of peripheral vascular disease whereas
others performed clinical examinations and calculated ankle
brachial pressure indices. Some risk factors were examined in
some studies but not in others. For example, data on smoking
were reported in 11 studies whereas the importance of diabetes
was examined in six studies only.
Figure 2 shows plots of odds ratios from individual studies and
combined odds ratios from random-effects models and table 4
gives combined odds ratios calculated by random and fixed-
effects models and probabilities from tests of heterogeneity. Male
sex showed the strongest association with AAA, whereas myo-
cardial infarction, peripheral vascular disease and smoking
showed moderate associations. Hypertension was only weakly
associated with AAA and no association was evident with
diabetes. There was significant heterogeneity between results
from individual studies for male sex and smoking, and in these
instances combined odds ratios from random-effects and fixed-
effects differed to some extent. Meta-regression analyses indicate
2238 titles ad abstracts of
potentially relevat articles
scrutinised
2053 articles judged to
be relevant
185 articles ordered and
examined in detail
167 articles excluded:
Review article (18%)
Study in selected group (16%)
Study on AAA surgery (16%)
Prognostic study (14%)
Insufficient data (15%)
Other reasons (21%)
18 articles from 14 studies
included
Figure 1 Flow chart showing progress in identification and selection
of relevant studies
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Table 1 Characteristics of population-based studies of asymptomatic abdominal aortic aneurysm
Inclusion criteria Number 
invited
Number screened
(%)Study Setting Age (years) Sex
Oxford45 Two large group practices in Oxford, UK 65–74 Men 824 426 (51.7)
Gloucester46 Four group practices in Gloucester, UK 65–74 Men 1,195 906 (76.0)
Malmö21,47 Citizens of Malmö, Sweden born in
even months in 1914 74 Men 499 375 (75.0)
Oslo25 Men registered with private Health
Maintenance Organisation in Oslo,
Norway 60–89 Men 2,674 1,246 (46.6)
Asola48 Residents of Asola, Italy >60 Men and women 1,122 648 (57.1)
Freemantle49 Members of bowling clubs, clients of a
shopping centre and retired residents
from Freemantle, Australia 60–80 Men and women Not reported 1,225 (–)
Birmingham50,51 Twenty-two general practices in
Birmingham, UK 60–75 Men 13,000 10,061 (77.4)
Rotterdam22 Residents of Rotterdam, The
Netherlands who participate in
Rotterdam Study ≥55 Men and women 6,947 5,419 (78.0)
Genoa52,53 Twenty-six general practices in Genoa,
Italy 65–75 Men and women 2,734 1,601 (58.5)
Chichester39,54 All general practices in Chichester
health district, UK 65–80 Men and women 7887 5,394 (68.4)
Viborg55 Residents of Viborg county, Denmark 65–73 Men 4,404 3,344 (76.0)
USA Counties23 People on Medicare lists from four US
Counties who participated in
Cardiovascular Health Study ≥65 Men and women 5,629 4,741 (84.2)
Edinburgh20 People on practice lists of ten practices
who participated in the Edinburgh
Artery Study 55–74 Men and women 1,592 1,156 (72.6)
USA Veterans24 People registered with 15 Department
of Veterans Affairs medical centers 50–79 Men and women 259,623 73,943 (28.5)
Table 2 Prevalence of asymptomatic abdominal aortic aneurysm in men and women
Study
Definition of AAA
(diameter or infra- to
supra-renal ratio [I/S])
Men Women
Number of AAAs /
Number successfully
screened
Prevalence 
in per cent 
(95% CI)
Number of AAAs /
Number successfully
screened
Prevalence 
in per cent 
(95% CI)
Oxford 40 mm or I/S >1.5 23 / 426 5.4 (3.5–8.0) n.a.
Gloucester >25 mm 71 / 906 7.8 (6.2–9.8) n.a.
Malmö >35 mm 39 / 338 11.5 (8.3–15.4) n.a.
Oslo ≥30 mm or I/S >1.5 41 / 500 8.2 (5.9–11.0) n.a.
Asola >25 mm n.r.a n.r.a 
Freemantle >30 mm 31 / 654 4.7 (3.2–6.7) 2 / 571 0.35 (0.04–1.3)
Birmingham ≥29 mm 706 / 9771 7.2 (6.7–7.8) n.a.
Rotterdam ≥35 mm or I/S >1.5 91 / 2217 4.1 (3.3–5.0) 21 / 3066 0.68 (0.42–1.0)
Genoa ≥30 mm 65 / 741 8.8 (6.8–11.0) 5 / 860 0.58 (0.19–1.4)
Chichester ≥30 mm 178 / 2342 7.6 (6.6–8.7) 40 / 3052 1.3 (0.9–1.8)
Viborg ≥30 mm 141 / 3344 4.2 (3.6–4.9) n.a.
USA Counties ≥30 mm or I/S >1.2 278 / 1956 14.2 (12.7–15.8) 173 / 2785 6.2 (5.3–7.2)
Edinburgh ≥30 mm n.r.b n.r.b 
USA Veterans ≥30 mm 3298 / 71373 4.6 (4.5–4.8) 25 / 1885 1.3 (0.8–1.8)
a: Sex-specific prevalence not reported. There were 20 AAAs among 354 men and 294 women, for a prevalence overall of 3.1% (95% CI: 1.9–4.7).
b: Sex-specific prevalence not reported. There were 34 AAAs among 1156 men and women, for a prevalence overall of 2.9% (95% CI: 2.0–4.1).
AAA: asymptomatic abdominal aneurysm
95% CI: 95% confidence interval
n.a.: not applicable; n.r.: no data, or no data in appropriate format reported.
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that both for male sex and smoking the prevalence of AAA
explained the heterogeneous results: the lower the prevalence of
AAA in a given study, the stronger the association between male
sex and AAA and smoking and AAA. The models predicted
that for a prevalence of AAA of 1% the odds ratio would be 8.63
for male sex and 3.84 for smoking. Conversely, for a prevalence
of AAA of 10% the corresponding odds ratios would be 2.33 and
1.77. There was no evidence of publication bias.
DISCUSSION
To our knowledge this is the first systematic review and meta-
analysis of population-based risk factor studies of AAA. The
results show that male sex, current cigarette smoking, and a
history of peripheral or coronary artery disease are all major risk
factors or risk indicators for screening-detected AAA, with
pooled odds ratios ranging from 2.3 to 5.7. Interestingly, hyper-
tension appears to be only weakly associated with AAA and no
association was found with diabetes. The population prevalence
of AAA varied widely which is not surprising considering the
differences between studies in terms of their definition of AAA,
the age and sex distribution of study populations, and the pre-
valence of risk factors and pre-existing morbidity.
We focused on population-based screening studies and thus
minimized detection, recall and interviewer bias. A spurious
association between a risk factor and AAA will result if the
presence or absence of this factor influences the probability of
detecting an aneurysm. For example, if many doctors believe that
patients with hypertension should be examined specifically then
diagnostic suspicion bias may be introduced in studies in which
case detection relies on routine clinical diagnosis or information
from death certificates.5 The case ascertainment in the screening
studies included in the present review was uniform within
studies, according to standardized criteria. Furthermore, in most
studies exposure information was collected before the diameter
of the abdominal aorta became known, effectively eliminating
interviewer and recall bias. Our literature search was com-
prehensive and covered different languages, which should have
minimized reporting biases.26 Finally, we examined possible
sources of heterogeneity, and found that the underlying pre-
valence of AAA explained some between-study heterogeneity.
This could reflect stronger risk factor associations, in relative
terms, in younger study populations who have a lower prevalence
of AAA, which is consistent with other cardiovascular condi-
tions.28 Alternatively, associations could be weaker because of a
Male sex
Odds ratio
Freem antle
Chichester
Rotterdam
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Genoa
US Veterans
Overall (95% CI)
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Overall (95% CI)
Peripheral Vascular Disease
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Figure 2 Forest plot of studies of risk factors for abdominal aortic aneurysm. Black squares indicate odds ratios and 95% confidence intervals
from individual studies and diamonds combined odds ratios and 95% confidence intervals from random-effects models. The size of the black
squares are proportional to the weight of the study in the analysis.
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broader, and less specific, definition of AAA in high prevalence
studies.
Our study illustrates several difficulties of systematic reviews of
observational studies.27 In contrast to randomized controlled
trials29 there are no agreed quality criteria for assessing cross-
sectional studies. Furthermore, we used unadjusted results
throughout, which allowed us to compare consistent estimates
across studies. However, these estimates may be biased in terms
of the aetiological importance of different risk factors. Only few
authors examined this issue in multivariable analyses. In the US
veterans study,24 the strength of the association of AAA with
male sex was attenuated when adjusting for smoking, a history
of cardiovascular disease and a range of cardiovascular risk
factors. We stress that our main objective was not to clarify the
aetiology of AAA but to identify risk factors or indicators that
may be useful to identify patients at increased risk in a screening
context. Keeping this in mind is also important when inter-
preting the weak association with hypertension: prospective
studies have shown that mortality from aortic aneurysm, parti-
cularly dissecting aneurysm, increases with blood pressure.30
Hypertension may thus be a relatively poor predictor of the risk
of asymptomatic AAA in the general population but at the same
Table 3 Definition of risk factors as described in original publications
Study
Myocardial 
infarction
Peripheral vascular
disease Smoking Hypertension Diabetes
Oxford n.r. History of
claudication
Current and former vs.
never smokers
n.r. n.r.
Gloucester n.r. n.r. Smokers vs. non smokers n.r. n.r.
Malmö Medical history ABPI <0.9 Smokers vs. non smokers DBP >105 mmHg or
antihypertensive
treatment
n.r.
Oslo n.r. n.r. Smokers vs. non smokers
and former smokers
Antihypertensive
treatment
Medical history
Asola n.r. n.r. Smokers vs. non smokers
and former smokers
Not defined n.r.
Freemantle n.r. n.r. n.r. n.r. n.r.
Birmingham ECG or enzymes
changes
n.r. >10 cigarettes/day vs.
others
SBP >160 mmHg or 
DBP >90 or
antihypertensive
treatment
Medical history
Rotterdam Medical history Rose questionnaire Smokers vs. non smokers SBP >160 mmHg or 
DBP >95 or
antihypertensive
treatment
Antidiabetic drug or
glycemia >11 mmol/l
Genoa n.r. History of
claudication
Smokers vs. non smokers SBP >160 mmHg or 
DBP >90 mmHg or
antihypertensive
treatment
Medical history
Chichester Medical history n.r. n.r. n.r. Medical history
Viborg Not defined Chart review Smokers vs. non smokers WHO definition n.r.
USA Counties Medical history Rose questionnaire
or ABPI <0.9
Smokers vs. non smokers Antihypertensive
treatment
Glycemia >11
mmol/l
Edinburgh Medical history ABPI ≤0.9 and drop
in ankle pressure
>20% or ABPI ≤0.7
or reactive
hyperaemia >35%
Smokers and recent
quitters (past 5 years) 
vs. others
SBP >160 mmHg or 
DBP >95 mmHg
n.r.
USA Veterans n.r. n.r. Ever smokers of >100
cigarettes vs. others
n.r. n.r.
ABPI: ankle brachial pressure index
SBP: systolic blood pressure
DBP: diastolic blood pressure
n.r.: no data, or no data in appropriate format reported.
Table 4 Combined odds ratios for the presence of asymptomatic abdominal aneurysm from meta-analysis
Risk factor
Number of
studies
Combined odds ratio (95% CI) p from test of
heterogeneityRandom-effects model Fixed-effects model
Sex (male vs. female) 6 5.69 (3.36–9.64) 3.96 (3.42–4.59) <0.0001
History of myocardial infarction (yes vs. no) 6 2.28 (1.90–2.74) 2.30 (1.92–2.75) 0.47
Peripheral vascular disease (yes vs. no) 8 2.50 (2.12–2.95) 2.48 (2.10–2.92) 0.74
Smoking (yes vs. no) 11 2.41 (1.94–3.01) 2.89 (2.63–3.16) 0.001
Hypertension (yes vs. no) 9 1.33 (1.14–1.55) 1.31 (1.14–1.49) 0.34
Diabetes (yes vs. no) 6 1.02 (0.81–1.29) 1.00 (0.80–1.26) 0.44
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time be an important risk factor for rupture in patients with
AAA.
Our review has other limitations. We did not consider a number
of variables, including age, race and lipid factors, because only
few studies reported relevant data. The strong association of
AAA with age is, however, well established both for men and
women. Epidemiological necropsy31,32 and screening studies22
documented a sharp increase in the prevalence of AAA after age
60, which in men reaches 6% to 9% and in women 2% to 3% by
age 80. Two studies23,24 examined the importance of race and
the study dominated by men,24 but not the one dominated by
women,23 found that black race was negatively associated with
AAA, in line with US mortality statistics that show racial
differences for men but not women.7 Three studies22–24
examined lipid factors, but used different methods. In the USA
Counties Study23 the prevalence of AAA was increased among
participants with HDL cholesterol levels below 40 mg/dl
(1 mmol/l) and slightly increased if LDL cholesterol was above
160 mg/dl (4.2 mmol/l). The Rotterdam study22 examined total
cholesterol and found only small differences whereas the results
from the Veterans Affair Cooperative Study24 are difficult to
interpret because analyses were based on inaccurate, self-
reported cholesterol levels. The exact etiologic role of lipid
factors thus remains unclear but they are likely to contribute to
any atherosclerotic component of the pathogenesis of aortic
aneurysms. Studies24,33,53 that examined the importance of a
positive family history found that such a history increased the
risk of AAA. Finally, all studies included in our review were
cross-sectional which means that strictly speaking it is impossible
to define the temporal sequence between exposures and
aneurysm formation.
What are the implications for screening for AAA? First, our
review shows that the numbers needed to screen (NNS)34 to
detect one patient with AAA are relatively low in the popula-
tions examined: the prevalences shown in table 3 translate to
NNS of 7 to 24 in men and 16 to 286 in women, which compares
favourably with other diseases for which routine screening is
currently recommended, such as breast cancer35,36 or colorectal
cancer.37 This is, however, insufficient evidence to recommend
screening for AAA. Most screening-detected aneurysms are
small. The risk of rupture is low in these cases and the majority
of patients will die from other causes, with their aneurysm
intact.38–40 The UK Small Aneurysm Trial,9 which enrolled
1090 patients with aneurysms of 40 to 55 mm diameter found an
operative mortality of 5.8% in patients allocated to early elective
surgery and a risk of rupture for small aneurysms of only 1% per
year in the group randomised to ultrasonographic surveillance.
Early surgery conferred no long-term survival advantage but
increased workload and costs for the health service.9 Regular
ultrasonography, rather than surgery, is therefore recommended
in smaller AAAs (diameters below 50 to 55 mm). Most surgeons
agree that aneurysms exceeding 55 mm in diameter should be
repaired if there are no concomitant conditions which would
substantially increase the risk of elective surgery, such as severe
cardiac or respiratory disease.
The NNS to prevent one death from ruptured AAA has recently
been determined by the Multicentre Aneurysm Screening Study
(MASS).41,42 This randomised controlled trial allocated 67,800
men aged 65 to 74 years to an invitation to undergo an abdominal
ultrasound scan (with follow-up scans or immediate surgery if
AAA was detected) or to a control group. In the intervention
group, 80% of men accepted the invitation and over four years
of follow-up AAA related mortality was reduced from 0.33% to
0.19% (risk reduction 42%, 95% confidence interval 22% to
64%).41 This means that 714 men need to be screened to prevent
one death, which in economic evaluation42 was found to be
only marginally cost-effective, although cost-effectiveness is
expected to improve over a longer period of follow up. The
cost-effectiveness of screening programmes could be increased if
screening was specifically targeted at the groups at high risk. One
programme, for example, used a scoring system which allocated
one point each for being male, diabetic, suffering from hyper-
tension and having raised lipids.43 Our findings indicate that a
history of diabetes, hypertension and dyslipidaemia should not
be used to identify people at increased risk of AAA. Targeted
screening is of course efficient only if most events occur in readily
defined subgroups of the population. Apart from being male our
data do not suggest that there are risk factors that are sufficiently
common and strong to form the basis of selective screening. A
study from Australia44 concluded that screening the 70% of men
who had ever smoked would detect 87% of aneurysms, which
represents only a marginal gain in efficiency. Selective screening
may, however, have a role in female populations. Decision
analysis and modelling based on our findings and those from
randomized trials could help identify the most promising target
groups and long-term screening strategies.
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